Institute of Medicine report calls for greater, faster availability of full clinical trial data sets, but with no authority and many loopholes, impact on status quo may be minimal.

European Medicines Agency plans to require publication of all raw clinical trial data as of January 2014. While industry fears this policy will result in release of confidential commercial information, GSK is making patient-level data available to certain researchers.

CooperSurgical is hit with second letter for misleading promotion of its copper-containing intrauterine contraceptive. Video lacked any safety information, agency says in request for corrective communication.